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New Target to Treat Lung Disease
Idiopathic pulmonary fibrosis (IPF) often results in irre-
versible lung damage and respiratory failure. As the
coagulation cascade has been implicated in IPF, Boren-
sztajn et al (Am J Pathol 2010, 177:2753–2764) hypoth-
esized that protease-activated receptor-2 (PAR-2), which
is activated by the coagulation cascade, was involved in
IPF pathogenesis. PAR-2 was up-regulated in patients
with IPF as well as in a mouse model of IPF. Mice defi-
cient in PAR-2 had less severe fibrosis, with fewer myo-
fibroblasts and reduced levels of collagen deposition.
These data implicate PAR-2 as a novel target for treat-
ment of IPF.
Matrix-Metalloproteinase 9 (MMP-9) Involved
in Cell Division
MMP degradation of the extracellular matrix is required
for cancer metastasis and wound healing; however, the
intracellular function of these molecules remains to be de-
fined. Sans-Fons et al (Am J Pathol 2010, 177:2870–2885)
found higher levels of MMP-9 activity in neuroblastoma cells
and bone marrow marcophages undergoing mitosis com-
pared with resting cells. They then compared MMP-9 ex-
pression with microtubule location; these data suggested
MMP-9 participation in both nuclear reorganization and
chromatid segmentation. Indeed, MMP inhibitors impaired
cell cycling and reduced cell culture growth. These data
indicate that MMP-9 may play an intracellular role in cell
division and cycling in neuroblastoma and macrophage
cells.
Parasites Block the Immune Response
The intracellular parasite Leishmania infects the phago-
cytic cells of the immune system. One type of phagocytic
cell, the dendritic cell, is an antigen-presenting cell crit-
ical for priming and polarizing T cells to fight infection.
Neves et al (Am J Pathol 2010, 177:2898–2911) explored
the effects of Leishmania infection on dendritic cell mat-
uration and activation. They found that infection did not
induce dendritic cell maturation and also prevented mat-
uration due to other stimuli. This inhibition was mediated
by the PI3K/Akt and ERK1/2, but not the JNK and p38/
MAPK, signaling pathways. In addition, parasitic infection
resulted in cleavage of the proinflammatory molecule
NF-B. Thus, Leishmania promotes immune evasion by
co-opting host signaling pathways.
Leptin Links Obesity and Tumor Growth
Obesity increases a patient’s risk of developing many
types of cancer, including breast cancer. Leptin, which
regulates food intake and energy homeostasis, has been
suggested to play a role in mammary tumorigenesis;
however, the mechanism governing these effects re-
mains unclear. Using a mouse model deficient in the
peripheral leptin receptor, Park et al (Am J Pathol 2010,
177:3133–3144) report attenuated tumor progression
and metastasis. This effect was dependent on Jak2/
STAT3 pathways and was tumor-cell autonomous. Mito-
chondrial function was preserved in these cells, which
had an enhanced capacity for -oxidation. Taken to-
gether, these results suggest that local leptin levels may
play a major role in tumor progression in the mammary
gland.
Nonspecific Tumor Inhibition by Small
Interfering RNAs (siRNAs)
Hepatocellular carcinoma, which is the third largest
cause of cancer-related deaths, has limited treatment
options. Gene silencing techniques have been sug-
gested for both treating established hepatocellular car-
cinoma and preventing cancer development by treating
underlying disease. Berge´ et al (Am J Pathol 2010, 177:
3192–3201) examined the effects of both nonspecific
control and neuropilin-1–specific siRNA in an animal
model of hepatocellular carcinoma. Both control and spe-
cific siRNAs resulted in decreased tumor volume and
vascular remodeling. Moreover, Toll-like receptor 3
(TLR-3) was up-regulated in hepatocellular carcinoma,
and polyinosinic-polycytidylic acid (a TLR-3 agonist)
mediated similar tumor regression and antiangiogenic
effects. Both TLR-3 and siRNA treatment inhibited en-
dothelial cell proliferation in an interferon-–specific
manner. Therefore, siRNA may inhibit tumor angio-
genesis nonspecifically by blocking endothelial cell
proliferation.
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